Loos, France

Nathalie Maubon

This inventor holds 1 USPTO granted patent. Top assignees: Chu De Nantes, Cnrs (Centre National De La Recherche Scientifique), Hcs Pharma. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathalie Maubon. Retrieved from https://idiyas.com/inventor/nathalie-maubon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathalie Maubon: Liver Organoid Innovation.

Introduction

Nathalie Maubon is an inventor associated with Loos, France. Her patent work concerns methods for producing liver organoids that may support research into liver biology and related applications.

Latest Patents

Maubon is associated with 1 patent: “Liver Organoid Manufacturing Methods, Liver Organoids Obtained with the Same, and Uses Thereof.” The disclosure describes preparing liver organoids using suitable cell culture media, a three-dimensional porous scaffold, and alternating hypoxic and normoxic conditions to guide stem-cell differentiation. The resulting organoids include hepatocytes, cholangiocytes, stellate cells, and sinusoidal endothelial cells. The patent describes liver-specific gene expression, LDL internalization, lipid accumulation, and strong CYP enzyme activity.

Career Highlights

Maubon’s listed institutional affiliations include the French National Institute of Health and Medical Research (Inserm) and Nantes Université. These organizations are associated with biomedical and academic research.

Collaborations

Her listed collaborators include Karim Si-Tayeb and Amandine Caillaud. Their shared work is connected to the development of liver organoid manufacturing methods and the characterization of the resulting organoids.

Conclusion

Nathalie Maubon’s patent contribution focuses on a method for producing functional liver organoids, combining scaffold-based culture and controlled oxygen conditions to advance organoid research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…